Your browser doesn't support javascript.
loading
Lifestyle, Epstein-Barr virus infection, and other factors could impede nasopharyngeal cancer survivorship: a five-year cross-sectional study in North Eastern India.
Chatterjee, Koustav; Roy, Sankar Deb; Chakraborty, Koushik; Haque, Asmaul; Chakrabarti, Sudipta; Mukherjee, Syamantak; Mal, Sudipa; Das, Nilanjana; Sahu, Sushil Kumar; Chattopadhyay, Nabanita Roy; Das, Piyanki; Reddy, R Rajendra; Aier, Moatoshi; Das, Ashok Kumar; Baishya, Nizara; Kannan, R Ravi; Puii, Zoreng; Zomawia, Eric; Singh, Yengkhom Indibor; Tsering, Sam; Riba, Komri; Rajasubramaniam, Shanmugam; Das, Bhabani Sankar; Suryawanshi, Amol Ratnakar; Chakraborty, Arindom; Ghatak, Sandeep; Choudhuri, Tathagata.
Affiliation
  • Chatterjee K; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
  • Roy SD; Department of Radiation Oncology, Eden Medical Center, Dimapur, Nagaland India.
  • Chakraborty K; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
  • Haque A; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
  • Chakrabarti S; Midnapore City College, Paschim Medinipur, Kuturia, Bhadutala, West Bengal India.
  • Mukherjee S; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
  • Mal S; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
  • Das N; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
  • Sahu SK; Department of zoology, Visva-Bharati, Santiniketan, West Bengal India.
  • Chattopadhyay NR; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
  • Das P; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
  • Reddy RR; Clinical Proteomics, Institute of Life Sciences, Bhubaneswar, India.
  • Aier M; Department of pathology, Eden Medical Center, Dimapur, Nagaland India.
  • Das AK; Department of Head & Neck Oncology, Dr. Bhubaneswar Borooah Cancer Institute, Guwahati, Assam India.
  • Baishya N; Department of Head & Neck Oncology, Dr. Bhubaneswar Borooah Cancer Institute, Guwahati, Assam India.
  • Kannan RR; Cachar Cancer Hospital and Research Centre. N. S. Avenue, Meherpur, Silchar, Assam India.
  • Puii Z; State Referral Hospital, Falkawn, Mizoram India.
  • Zomawia E; State Referral Hospital, Falkawn, Mizoram India.
  • Singh YI; Department of Radiotherapy, Regional Institute of Medical Sciences, Imphal, Manipur India.
  • Tsering S; Tertiary cancer center, TomoRiba Institute Of Health, and Medical Sciences, Naharlagun, Arunachal Pradesh India.
  • Riba K; Tertiary cancer center, TomoRiba Institute Of Health, and Medical Sciences, Naharlagun, Arunachal Pradesh India.
  • Rajasubramaniam S; Division of Genetic Disorders, ICMR-National Institute of Research in Tribal Health, NIRTH Complex, Jabalpur, Madhya Pradesh India.
  • Das BS; Clinical Proteomics, Institute of Life Sciences, Bhubaneswar, India.
  • Suryawanshi AR; Clinical Proteomics, Institute of Life Sciences, Bhubaneswar, India.
  • Chakraborty A; Department of Statistics, Visva-Bharati, Santiniketan, West Bengal India.
  • Ghatak S; Division of Animal and Fishery Science, ICAR Research Complex for North East Hill Region, Umiam, Meghalaya India.
  • Choudhuri T; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
Virusdisease ; 33(4): 371-382, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36447816
ABSTRACT
Nasopharyngeal Carcinoma (NPC) is one of the leading cancers in India's north-eastern (NE) region affecting a section of the population each year. A proportion of the NPC cases are observed to recur even after therapy, indicating the involvement of other factors. We aimed to explore the NPC and Epstein-Barr virus (EBV) burden in the NE region and investigate the prognostic factors for the NPC patients' poor survival and recurrence. NPC patients' information was obtained from different state hospitals between 2014 and 2019. PCR and Sanger sequencing were performed to detect EBV types. Statistical analysis, including forest plot analysis, Kaplan-Mayer survival plot, Log-rank test, cox hazard regression, and Aalen's additive regression model, were performed to determine prognostic factors for the NPC patients' lower survival and recurrence. We observed an increased incidence of NPC and EBV infection in the past five years. Step-wise statistical analyses pointed out that variable such as non-professionals (B = 1.02, HR = 2.8, 95%CI = 1.5,4.9) workers (B = 0.92, HR = 2.5, 95%CI = 1.4,4.4), kitchen cum bedroom (B = 0.61, HR = 1.8, 95%CI = 1.2,2.8), mosquito repellent (B = 0.60, HR = 1.7, 95%CI = 1.1,2.7), nasal congestion (B = 0.60, HR = 1.8, 95%CI = 1.2,2.8), lower haemoglobin level (B = 0.92, HR = 2.5, 95%CI = 1.3,4.9), tumor stage IV (B = 2.8, HR = 1.8, 95%CI = 1.6,14.3), N2 (B = 1.4, HR = 4.0, 95%CI = 1.8,9.1), N3 (B = 1.9, HR = 6.4, 95%CI = 2.8,15.3), and M+ (B = 2.02, HR = 7.5, 95%CI = 4.1,13.7) revealed significant correlation with NPC patients' poor prognosis (p < 0.05). The presence of viral factors also showed a significant association with NPC patients' decreased survival. We concluded that factors related to day-to-day life with EBV infection could be the individual predictor for NPC incidence, lower survival, and disease recurrence. Supplementary Information The online version contains supplementary material available at 10.1007/s13337-022-00789-5.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Virusdisease Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Virusdisease Year: 2022 Document type: Article
...